Table 5:
Estimates of global economic burden of stroke, 2017 and 2050
| Low estimate 2017 (US$ billions) | High estimate 2017 (US$ billions) | Low estimate 2050 (US$ billions) | High estimate 2050 (US$ billions) | |
|---|---|---|---|---|
| High-income countries | 417·0 | 597·6 | 436·6–655·9 | 578·3–997·0 |
| Upper-middle-income countries | 279·1 | 410·0 | 273·5–743·6 | 334·2–1026·4 |
| Lower-middle-income countries | 48·3 | 64·8 | 159·5–200·4 | 170·4–252·5 |
| Low-income countries | 2·6 | 4·9 | 11·2–22·0 | 13·5–34·1 |
| Global | 745·9 | 1077·2 | 880·8–1621·9 | 1096·4–2310·0 |
The total cost includes both direct costs (associated with providing care for incident stroke cases and deaths) and indirect cost (ie, loss of income). Direct costs were calculated using previously described methods.8 The 2017 estimates comprise the low-cost and high-cost scenario estimates from Owolabi et al.8 Low estimates for 2050 assume that costs of treatment and rehabilitation grow at a rate 1% above the rate of non-medical inflation. High estimates for 2050 assume that costs of treatment and rehabilitation grow at 3% above the rate of non-medical inflation. For both low and high 2050 estimates, the range reflects the low-cost and high-cost estimates for acute and post-acute care in Owolabi et al.8